P3 HEALTH PARTNERS INC Stock Price, News & Analysis

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the upcoming Jefferies Healthcare Services Conference. The company's management team will engage in a fireside chat on September 30, 2025, at 2:25 PM Central Time.

Investors can access the presentation via webcast on P3's Investor Relations website, with a replay available for 30 days following the event.

Catalyst Solutions (NYSE:PIII) has successfully launched its Professional Health Partners Services (P3) Implementation across four states. The implementation, completed in May 2025, supports P3 Health Partners in delivering population health management and administrative services for Medicare members.

The project spans Arizona, Oregon, Nevada, and California, covering eleven active health plans and serving nearly 68,000 members. Catalyst provides support through Configurations, Claims, and Provider Call Center services using a hybrid onshore/offshore model. The implementation was notably completed in just 60 days, demonstrating Catalyst's efficient execution capabilities.

P3 Health Partners (NASDAQ: PIII) reported Q2 2025 financial results, demonstrating resilience in its core business despite industry challenges. The company achieved flat medical cost trends and recorded total revenue of $355.8 million, down 6% year-over-year. Average at-risk membership decreased 9% to 115,000 members due to network rationalization.

The company's medical margin was $30.6 million ($89 PMPM), while adjusted EBITDA showed a loss of $17.1 million ($50 PMPM). Notably, P3 has identified $120-$170 million in additional EBITDA opportunities for 2026. The company revised its FY2025 guidance, projecting total revenues between $1.35-$1.5 billion and adjusted EBITDA loss between $69-39 million.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has scheduled its second quarter 2025 earnings release and conference call for August 14, 2025.

The company will release its Q2 2025 financial results and file its Form 10-Q on the same day. Management will host a conference call at 4:30 PM ET to discuss the results. Investors can access the call via toll-free number 1-833-316-0546 (US) or 1-412-317-0692 (International).

A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. An archived recording will remain accessible for 90 days following the call.

P3 Health Partners (NASDAQ: PIII) reported its Q1 2025 financial results, showing mixed performance. The company's revenue decreased 4% to $373.2 million compared to $388.5 million in Q1 2024. Average at-risk membership declined 8% to 115,900 members, while per-member funding PMPM increased 8% to $1,063. Medical margin fell to $17.2 million from $36.6 million, impacted by a $23 million negative adjustment from prior year claims. Adjusted EBITDA loss widened to $22.2 million from $19.8 million. Despite challenges, CEO Aric Coffman highlighted that three of four markets achieved breakeven or better in Q1, and the company's turnaround plan is ahead of schedule. P3 affirmed its 2025 guidance, projecting total revenues of $1.35-1.5 billion and at-risk members between 109,000-119,000.

P3 Health Partners (NASDAQ: PIII) has announced it will release its first quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. The company will host a conference call with management to discuss the results at 4:30 PM ET/1:30 PM PT on the same day.

Investors can join the conference call through the toll-free number 1-833-316-0546 (US) or internationally at 1-412-317-0692. A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. The webcast recording will remain accessible on the company's website for 90 days following the call.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team is scheduled to deliver a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time.

Investors and interested parties can access the presentation through a webcast available on P3's Investor Relations Website at ir.p3hp.org. The presentation recording will remain accessible on the company's investor relations webpage for 30 days following the event.

P3 Health Partners (NASDAQ: PIII) reported its Q4 and full-year 2024 financial results, showing mixed performance. Full-year revenue reached $1.50 billion, up 18% year-over-year, with capitated revenue increasing 18% to $1.48 billion.

The company's at-risk membership grew 14% to 123,800 members. However, financial metrics showed significant challenges: Full-year net loss widened to $310.4 million from $186.4 million, while medical margin decreased 37% to $85.5 million. Q4 2024 results included total revenue of $370.7 million (up 7%) but showed a gross profit loss of $39.5 million.

CEO Aric Coffman highlighted the company's fundamentally strong business model and identified $130M+ in programmatic opportunities to improve financial sustainability.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced it will release its fourth quarter and full year 2024 financial results on March 27, 2025. The company will host a conference call with management to discuss the results at 1:30 PM PT/4:30 PM ET on the same day.